Dhaka Bureau: 10 first- and second-line antibiotics have lost 90% effectiveness against the six most deadly bacteria. Bangabandhu Sheikh Mujib Medical University research has found this information.
Doctors say that 1 lakh 70 thousand people die every year due to infection in the country. Deaths will increase if antibiotic misuse is not reduced.
Antibiotics do not work against 82% of bacteria. Antibiotics do not work against 82% of bacteria. Among the bacteria that cause human illness in the world, six are the most harmful, including Klebsiella, E. coli, and Salmonella. Due to these, various diseases, including pneumonia, diarrhea, and typhoid, occur.
Researchers at Bangabandhu Sheikh Mujib Medical University say that 10 antibiotics, which are most commonly used to destroy bacteria, are not meeting the expected results.
Of these, amoxacillin and ciprofloxacin do not work in 97% of cases. Even stronger drugs, such as cefixime and ceftriaxone, work in only 10% of patients.
Antibiotics are ineffective in 29 percent of patients. Antibiotics are ineffective for 29 percent of patients. Bangabandhu Sheikh Mujib Medical University Associate Professor Dr. Fazle Rabbi Chowdhury said, ‘The situation has become really terrible now. Thus, if we continue to use reserve group antibiotics, there is a possibility that these too will soon become ineffective. Then, when the infected patients come, it will be seen in the diagnosis that they are resistant to all antibiotics. The doctors were helpless.’
The loss of antibiotic effectiveness against germs results in longer recovery times for patients. Medical expenses and loss of life are also increasing.
67% of commonly used antibiotics are ineffective. 67% of commonly used antibiotics are ineffective. Bangabandhu Sheikh Mujib Medical University Vice-Chancellor Prof. Sharfuddin Ahmed urged all doctors to prescribe medicines after completing the correct diagnosis.
More than 40 types of antibiotics are used in the country. Most of them are very functional. But the danger is that such antibiotics are no longer being produced.
